<DOC>
	<DOC>NCT00609284</DOC>
	<brief_summary>The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.</brief_summary>
	<brief_title>Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux</brief_title>
	<detailed_description />
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, larynx Stage III IV (T0T4, N0N2b, M0) Not resected Karnofsky PS&gt;=80 Informed consent signed Contra indication to chemotherapy or cetuximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Stage III</keyword>
	<keyword>Stage IV</keyword>
	<keyword>locally advanced</keyword>
</DOC>